Here are three things to know.
1. The agency approved Prevymis as both a tablet, which will cost $195 per day, and as an infection, which will cost $270 per day.
2. The drug’s recommended dosing is once-daily for 100 days after the stem cell transplant.
3. Merck plans to launch Prevymis in December.
More articles on supply chain:
Sens. Chuck Grassley, Elizabeth Warren ask CMS to clarify position on unique device identifiers by Dec. 1
Indiana claims Nantworks failed to fulfill promises to state, seeks $1.4M
7 must-reads for supply chain leaders this week
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.